Monday October 26, 2020 0 comments
ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI) today announced it hired Neil Friery as president and chief operating officer of its Monitoring Solutions Division.
As president and COO, Friery will lead operations, sales, marketing and product development of the Monitoring Solution Division, including the production and launch of the CM-1500 Blood Volume Monitor that was granted 510(k) clearance by the U.S. Food and Drug Administration earlier this year.
"I am excited to bring Neil in to run our Monitoring Solutions Division,” said Thomas Sandgaard, founder and CEO. “We continue to build out this division, adding personnel in clinical research and sales and marketing.
“With Neil's background, I am confident we will soon have our technology become the standard-of-care for early detection of internal bleeding in surgical and post-surgical recovery.
“While the CM-1500 is already in full production, the next generation (CM-1600) is well under way and we hope to apply for FDA clearance for that model soon."
Friery previously worked as senior VP and GM at Zimmer Biomet, leading the Surgical Division of this Fortune 500 musculoskeletal healthcare company. During his tenure at Zimmer Biomet, he oversaw all functional aspects of the surgical organization and was instrumental in the build-out of a direct sales force, several new product launches, as well as strategic acquisitions and distribution agreements doubling the division's revenue to $400M.
Prior to his appointment as senior VP and GM, Friery was director of finance for the Surgical Division.
Friery graduated with honors from the University of Notre Dame with a Bachelor’s of Business Administration degree. He is currently an Entrepreneur in Residence at Case Western Reserve University and a member of the board of directors at West Side Catholic Center.